(Press-News.org) Contact information: William Allstetter
allstetterw@njhealth.org
303-398-1002
National Jewish Health
Bronchial thermoplasty shows long-term effectiveness for asthma
Data show improvements maintained for 5 years after procedure
DENVER – The beneficial effects of bronchial thermoplasty, a non-pharmacologic treatment for asthma, last at least five years, according to researchers at National Jewish Health and other institutions. The therapy, in which heat is applied to a patient's airways during a bronchoscopy procedure, was approved by the U.S. Food and Drug Administration in April 2010. Among other criteria, the researchers report in the December issue of the Journal of Allergy and Clinical Immunology that reductions in severe asthma exacerbations, emergency department visits, medication use and missed workdays continued out to five years after the procedure was performed.
"These data add to the growing body of evidence that bronchial thermoplasty has a long-term benefit and is an important option for patients whose moderate to severe asthma is not controlled by medications," said Michael Wechsler, MD, lead author of the study and professor of medicine at National Jewish Health.
During bronchial thermoplasty a physician uses a specialized bronchoscope to apply radio frequency energy to heat the airways. The treatment is done in three separate procedures approximately three weeks apart, and reduces smooth muscle surrounding the airways, which can constrict and reduce airflow in asthma.
Earlier research showed that most patients who underwent bronchial thermoplasty in the AIR2 trial experienced benefits for at least two years. The current study extends that to five years.
In the year before bronchial thermoplasty, 52 percent of patients suffered severe exacerbations of their asthma. That dropped to 31 percent in the first year following the treatment and averaged 29 percent over the five years following the procedure.
After bronchial thermoplasty 78 percent fewer patients made visits to the emergency department, dropping from about 30 percent of patients to less than 7 percent.
Missed workdays dropped 66 percent in the five years after bronchial thermoplasty. Average use of corticosteroid medications also dropped 17 percent.
Stable rates of respiratory adverse events and respiratory-related hospitalizations as well as unchanged CT scans in years two through five indicated that there were no significant safety concerns with the procedure.
### END
Bronchial thermoplasty shows long-term effectiveness for asthma
Data show improvements maintained for 5 years after procedure
2013-12-03
ELSE PRESS RELEASES FROM THIS DATE:
Integrated pest managment techniques can help manage the Bagrada bug
2013-12-03
Integrated pest managment techniques can help manage the Bagrada bug
The Bagrada bug, an invasive stink bug, was discovered in the western hemisphere in 2008 near Los Angeles, CA, presumably introduced via container shipments arriving at the Port of ...
A new weapon in the war against superbugs
2013-12-03
A new weapon in the war against superbugs
Tel Aviv University researchers find a protein that viruses use to kill bacteria
In the arms race between bacteria and modern medicine, bacteria have gained an edge. In recent decades, bacterial resistance to ...
Energy drinks plus alcohol pose a public health threat
2013-12-03
Energy drinks plus alcohol pose a public health threat
ANN ARBOR—Mixing energy drinks with alcohol is riskier than just drinking alcohol alone, according to a new study that examines the impact of a growing trend among young adults.
Published in the current issue ...
A living desert underground
2013-12-03
A living desert underground
In the perpetual darkness of a limestone cave, UA researchers have discovered a surprisingly diverse ecosystem of microbes eking out a living from not much more than drip water, rock and air
Hidden underneath the hilly grasslands studded ...
Ethnic identification helps Latina adolescents resist media barrage of body images
2013-12-03
Ethnic identification helps Latina adolescents resist media barrage of body images
CORVALLIS, Ore. – A strong sense of ethnic identity can help Latina girls feel positive about their body and appearance, a new study concludes, even as this group ...
Aerobic fitness and hormones predict recognition memory in young adults
2013-12-03
Aerobic fitness and hormones predict recognition memory in young adults
(Boston) – Researchers at Boston University School of Medicine (BUSM) have found further evidence that exercise may be beneficial for brain health and cognition. The findings, which ...
'Designer sperm' inserts custom genes into offspring
2013-12-03
'Designer sperm' inserts custom genes into offspring
New research in The FASEB Journal suggests that altering genes in sperm and then inducing fertilization, produces new genes that are present and active in the embryos and inherited ...
Bothersome pain afflicts half of older Americans
2013-12-03
Bothersome pain afflicts half of older Americans
Findings from a unique study underscore need for public health action on pain and disability in the elderly, reports PAIN®
Philadelphia, December 2, 2013 – More than half of older adults in the United States – ...
Mission possible: Simulation-based training and experimentation on display
2013-12-03
Mission possible: Simulation-based training and experimentation on display
A unique system that merges the virtual and real worlds to train Sailors for combat scenarios was unveiled Dec. 2 in Orlando.
The Office of Naval Research (ONR) is demonstrating ...
NASA investigating the life of Comet ISON
2013-12-03
NASA investigating the life of Comet ISON
After several days of continued observations, scientists continue to work to determine and to understand the fate of Comet ISON: There's no doubt that the comet shrank in size considerably as it rounded ...
LAST 30 PRESS RELEASES:
First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer
Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial
Higher blood pressure in childhood linked to earlier death from heart disease in adulthood
AI helped older adults report accurate blood pressure readings at home
High blood pressure in childhood and premature cardiovascular disease mortality
Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations
Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC
Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy
FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC
Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study
New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients
Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds
COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC
CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC
Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital
New medication lowered hard-to-control high blood pressure in people with chronic kidney disease
Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment
New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment
Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor
Study prompts new theory of human-machine communication
New method calculates rate of gene expression to understand cell fate
Researchers quantify rate of essential evolutionary process in the ocean
Innovation Crossroads companies join forces, awarded U.S. Air Force contract
Using new blood biomarkers, USC researchers find Alzheimer’s disease trial eligibility differs among various populations
Pioneering advances in in vivo CAR T cell production
Natural medicines target tumor vascular microenvironment to inhibit cancer growth
Coral-inspired pill offers a new window into the hidden world of the gut
nTIDE September2025 Jobs Report: Employment for people with disabilities surpasses prior high
When getting a job makes you go hungry
Good vibrations could revolutionize assisted reproductive technology
[Press-News.org] Bronchial thermoplasty shows long-term effectiveness for asthmaData show improvements maintained for 5 years after procedure